期刊文献+

抑睾调经汤联合达英-35治疗青春期PCOS临床观察 被引量:1

Clinical observation on treating adoleseent PCOS with Yigao Tiaojing decoction plus Diane-35
暂未订购
导出
摘要 目的:比较单用达英-35和联用达英-35及抑睾调经汤治疗青春期多囊卵巢综合征(Polycystic Ovary Syndrome,PCOS)的效果。方法:将96例确诊的青春期多囊卵巢综合征患者分为单用组和联用组,用药前和用药后均抽血测定卵泡刺激素(FSH)、黄体生成素(LH)、睾酮(T)在循环血中的游离浓度以及测量双侧卵巢的体积和卵泡的数量。结果:单用组和联用组在治疗前的三种激素水平,卵巢体积和卵泡数量无明显差异(P>0.05)。治疗青春期多囊卵巢综合征三个月后,联用组比单用组在降低三种激素水平,减少卵巢体积和卵泡数量有显著差异(P<0.05)。结论:联用达英-35和抑睾调经汤,能够显著改善患者卵巢多囊状态,对多囊卵巢有一定的治疗作用。 To compare Diane-35 alone and combined with Diane-35 and the Yigao Tiaojing decoction treating adolescent polycystic ovary syndrome (Polycystic Ovary Syndrome, PCOS) results. Methods: 96 cases diagnosed in adolescents with polycystic ovary syndrome patients were divided into single-use group and combination group, before treatment and after treatment were measured for blood measuring follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T) in the concentration of free circulating blood volume and ovaries as well as the number of follicles. Results:Alone group and combination group before treatment of the three hormone levels, ovarian volume and the number of follicles was no significant difference (P〉0.05). Treatment of adolescents with polycystic ovary syndrome after three months, together with a group than alone group three hormones in the lower levels, reduce the number of follicles and ovarian volume were significantly different (P〈0.05). Conclusion:Combined with Diane-35 and the Yigao Tiaojing decoction can significantly improve the condition of patients with polycystic ovaries, women with polycystic ovary have a therapeutic effect.
出处 《中医临床研究》 2014年第19期80-82,共3页 Clinical Journal Of Chinese Medicine
关键词 达英-35 抑睾调经汤 中西医结合 DIANE-35 PCOS Yigao Tiaojing decoction PCOS The integrative medicine
  • 相关文献

参考文献6

二级参考文献31

  • 1郑建淮,曹缵孙,任娟.罗格列酮和二甲双胍治疗多囊卵巢综合征患者的临床疗效比较[J].实用妇产科杂志,2005,21(9):541-544. 被引量:8
  • 2李昕,林金芳.肥胖型多囊卵巢综合征患者临床及内分泌代谢特征的研究[J].中华医学杂志,2005,85(46):3266-3271. 被引量:141
  • 3陈子江.高度重视多囊卵巢综合征的规范化诊断与治疗[J].中华妇产科杂志,2007,42(5):289-290. 被引量:69
  • 4张显林,刘先哲.多囊卵巢综合症与心血管疾病相关性的探讨[J].现代生物医学进展,2007,7(8):1256-1257. 被引量:15
  • 5The Rotterdam ESHRE/ASRM- Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long - term health risks related to polycystic ovary syndrome [J]. Hum Reprod, 2004, 19 (1) : 41.
  • 6Azziz R, Carmina E, Dewailly D et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline [J]. J Clin Endocrinol Metab, 2006, 91 (11): 4237.
  • 7Falsetti L, Gambera A, Tisi G. Efficacy of the combination ethinyl oestradiol and cyproterone acetate on endocrine, clinical and ultrasono- graphic profile in polycystic ovarian syndrome[J]. Hum Repmd, 2001, 16 (1): 36.
  • 8Cagnacci A, Paoletti AM, Renzi A. Glucose metabolism and insulin resistance on women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel [J]. Clin Endocrinol Metab, 2003, 88 (8) : 3621.
  • 9Shi Y, Guo M, Yan J et al. Analysis of clinical characteristics in large - scale Chinese women with po!ycystic ovary syndrome [J]. Neuroendocrinol Lett, 2007, 28 (6): 807.
  • 10Wachs DS, Coffler MS, Malcom PJ et al. Serum anti - mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women [J]. J Clin Endocrinol Metab, 2007, 92 (5) : 1871.

共引文献78

同被引文献18

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部